Estimation the medical cost of multiple sclerosis in Iran; 2019–2020

Table 2 Total Cost of Determining and Diagnosing of the MS Risk in 2019–20

Service	Frequency	IHIO Total cost ($)	Country Total Cost ($)	Share in the Total Cost (%)
Specialized Visits	3888	29,808	59,616	17.10
MRI^a	2991	88,104.29	176,208.59	50.55
CSF^b	122	3026.26	6052.52	1.73
EP^c	82	1271.27	2542.55	0.72
Diagnosis (laboratory tests)
CBC	14,662	6799.01	13,598.04	3.90
ALT SGPT	11,702	5697.89	11,395.8	3.26
AST SGOT	11,438	5680.26	11,360.53	3.25
HBS Ag	2334	7607.04	15,214.09	4.36
HCV Ab	2396	6341.90	12,683.82	3.63
ALP	6209	2613.55	5227.101	1.49
TSH	4643	5790.79	11,581.59	3.32
CRP	2857	1003.82	2007.657	0.57
LDL	1500	925.23	1850.462	0.53
Anti-HCV	2090	6368.08	12,736.17	3.65
Hydroxy Vitamin-D	1494	3249.84	6499.69	1.86
Total Cost		174,287.31	348,574.635

ISSN: 1472-6963